puc-header

Integrin αvβ8 on T Cells is Responsible for Suppression of Anti-Tumor Immunity in Syngeneic Models and is a Promising Target for Tumor Immunotherapy

53 Pages Posted: 19 May 2020 Publication Status: Published

See all articles by Eswari Dodagatta-Marri

Eswari Dodagatta-Marri

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Hsiao-Yen Ma

University of California, San Francisco (UCSF) - Lung Biology Center

Benjia Liang

University of California, San Francisco (UCSF) - Lung Biology Center

John Li

University of California, San Francisco (UCSF) - Lung Biology Center

Dominique S. Meyer

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Kai-Hui Sun

University of California, San Francisco (UCSF) - Lung Biology Center

Xin Ren

University of California, San Francisco (UCSF) - Lung Biology Center

Bahar Zivak

University of California, San Francisco (UCSF) - Department of Dermatology

Michael D. Rosenblum

University of California, San Francisco (UCSF) - Department of Dermatology

Mark B. Headley

University of California, San Francisco (UCSF) - Department of Pathology

Lauren Pinzas

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Nilgun I. Reed

University of California, San Francisco (UCSF) - Lung Biology Center

Joselyn S. Del Cid

University of California, San Francisco (UCSF) - Lung Biology Center

Maeva Adoumie

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Byron C. Hann

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Sharon Yang

Pfizer, Inc. - Comparative Medicine

Anand Giddabasappa

Pfizer, Inc. - Oncology Research Unit

Kavon Noorbehesht

Pfizer, Inc. - Oncology Research Unit

Bing Yang

Pfizer, Inc. - Oncology Research Unit

Joseph Dal Porto

Pfizer Centers for Therapeutic Innovation

Tatsuya Tsukui

University of California, San Francisco (UCSF) - Lung Biology Center

Kyle Niessen

Pfizer Centers for Therapeutic Innovation

Amha Atakilit

University of California, San Francisco (UCSF) - Lung Biology Center

Rosemary Akhurst

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Dean Sheppard

University of California, San Francisco (UCSF) - Lung Biology Center

More...

Abstract

The αvβ8 integrin is a key activator of transforming growth factor β(TGFβ), which has been shown to inhibit anti-tumor immunity. Previous work has suggested that αvβ8 on tumor cells could modulate tumor growth and responses to immune checkpoint blockade. We now show that a potent blocking monoclonal antibody against avb8 (ADWA-11) causes growth suppression or complete regression in syngeneic models of squamous cell carcinoma (CCK168), mammary cancer (EMT-6), colon cancer (CT26), and prostate cancer (TRAMPC2), especially when it is combined with other immunomodulators (anti-PD-1, anti-CTLA-4 or 4-1BB) or radiotherapy.  αvβ8 is expressed on tumor cells in some of these models, but tumor cell expression of avb8 is not essential for the beneficial effects of ADWA-11 therapy. αvβ8 is consistently expressed at highest levels on CD4+CD25+ T cells within tumors, and specific deletion of Itgb8 from T cells is as effective as ADWA-11 in suppressing tumor growth. Treatment with ADWA-11 increases expression of a suite of genes in tumor infiltrating CD8+ T cells that are normally inhibited by TGFβ and are involved in tumor cell killing, including Granzyme B and Interferon-g. These findings solidify αvβ8 integrin as a promising target for cancer immunotherapy, even for tumors that do not express this integrin.

Suggested Citation

Dodagatta-Marri, Eswari and Ma, Hsiao-Yen and Liang, Benjia and Li, John and Meyer, Dominique S. and Sun, Kai-Hui and Ren, Xin and Zivak, Bahar and Rosenblum, Michael D. and Headley, Mark B. and Pinzas, Lauren and Reed, Nilgun I. and Del Cid, Joselyn S. and Adoumie, Maeva and Hann, Byron C. and Yang, Sharon and Giddabasappa, Anand and Noorbehesht, Kavon and Yang, Bing and Dal Porto, Joseph and Tsukui, Tatsuya and Niessen, Kyle and Atakilit, Amha and Akhurst, Rosemary and Sheppard, Dean, Integrin αvβ8 on T Cells is Responsible for Suppression of Anti-Tumor Immunity in Syngeneic Models and is a Promising Target for Tumor Immunotherapy. Available at SSRN: https://ssrn.com/abstract=3588885 or http://dx.doi.org/10.2139/ssrn.3588885
This version of the paper has not been formally peer reviewed.

Eswari Dodagatta-Marri

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Hsiao-Yen Ma

University of California, San Francisco (UCSF) - Lung Biology Center ( email )

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Benjia Liang

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

John Li

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Dominique S. Meyer

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Kai-Hui Sun

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Xin Ren

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Bahar Zivak

University of California, San Francisco (UCSF) - Department of Dermatology

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Michael D. Rosenblum

University of California, San Francisco (UCSF) - Department of Dermatology

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Mark B. Headley

University of California, San Francisco (UCSF) - Department of Pathology

Third Avenue and Parnassus
San Francisco, CA CA 94143
United States

Lauren Pinzas

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Nilgun I. Reed

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Joselyn S. Del Cid

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Maeva Adoumie

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Byron C. Hann

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center ( email )

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Sharon Yang

Pfizer, Inc. - Comparative Medicine

235 East 42 Street
New York, NY 10017
United States

Anand Giddabasappa

Pfizer, Inc. - Oncology Research Unit

235 East 42 Street
New York, NY 10017
United States

Kavon Noorbehesht

Pfizer, Inc. - Oncology Research Unit

235 East 42 Street
New York, NY 10017
United States

Bing Yang

Pfizer, Inc. - Oncology Research Unit

235 East 42 Street
New York, NY 10017
United States

Joseph Dal Porto

Pfizer Centers for Therapeutic Innovation

United States

Tatsuya Tsukui

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Kyle Niessen

Pfizer Centers for Therapeutic Innovation

United States

Amha Atakilit

University of California, San Francisco (UCSF) - Lung Biology Center

Third Avenue and Parnassus
San Francisco, CA 94143
United States

Rosemary Akhurst

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center ( email )

Box 0981, UCSF
San Francisco, CA 94143-0981
United States

Dean Sheppard (Contact Author)

University of California, San Francisco (UCSF) - Lung Biology Center ( email )

San Francisco, CA 94143
United States

Click here to go to Cell.com

Paper statistics

Downloads
41
Abstract Views
1,040
PlumX Metrics